Insider Transactions in Q4 2023 at Greenwich Life Sciences, Inc. (GLSI)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 10
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
5,000
+0.09%
|
$50,000
$10.17 P/Share
|
|
Nov 03
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
3,500
+0.07%
|
$31,500
$9.11 P/Share
|
|
Oct 27
2023
|
Jaye Thompson VP Clinical Reg Affairs |
BUY
Open market or private purchase
|
Direct |
500
+0.19%
|
$4,000
$8.57 P/Share
|
|
Oct 26
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
2,500
+0.05%
|
$17,500
$7.97 P/Share
|
|
Oct 25
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
2,500
+0.05%
|
$17,500
$7.91 P/Share
|
|
Oct 10
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
1,000
+0.02%
|
$9,000
$9.07 P/Share
|
|
Oct 04
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
2,000
+0.04%
|
$16,000
$8.63 P/Share
|